MICHAEL ZORNITZER: Open Payments
NPI 1033275813 · LIVINGSTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305 in 18 payments from 5 companies in 2025. Trend: 2023 $741 · 2024 $769 · 2025 $305
Food & beverage: $305
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $82 |
| Neos Therapeutics, LP | 5 | $80 |
| Lundbeck LLC | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
Products named: REXULTI, VRAYLAR, Adzenys XR-ODT, EXXUA, INGREZZA.
Industry payments across NJ — which companies pay providers there.
